Business
Pharmaceutical Lobbying and China Deal
The 17 pharmaceutical companies backing TrumpRx spent over $130 million on federal lobbying in 2025, a significant increase from the previous year. A deal with a Chinese partner is also under discussion.
Coverage timeline — 1 article
STAT News
The 17 pharmaceutical companies anchoring TrumpRx poured more than $130 million into federal lobbying in 2025 — a nearly 23% surge
2026-05-12 13:25 UTC